Skip to content

Type 1c Von Willebrand Disease C5676305

Published: July 22, 2026Updated: August 20, 2026

A mild inherited bleeding disorder where the body has reduced levels of a protein needed for blood clotting, managed with medication if needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Mucocutaneous bleeding

(hematologic)

Menorrhagia (heavy menstrual bleeding)

(hematologic)

Epistaxis (nosebleeds)

(hematologic)

Prolonged bleeding after injury

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Desmopressin (DDAVP) Therapy

First-line pharmacological treatment that increases von Willebrand factor and Factor VIII levels in the bloodstream. Administered intranasally, orally, or intravenously before surgical procedures or to manage bleeding episodes.

medication
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Antifibrinolytic Agents

Medications such as tranexamic acid or aminocaproic acid that help stabilize blood clots by preventing their breakdown. Particularly useful for mucosal bleeding, dental procedures, and heavy menstrual bleeding.

medication

Additional treatment options

Von Willebrand Factor Replacement

Intravenous infusion of plasma-derived von Willebrand factor concentrates for patients who do not respond adequately to desmopressin or in emergency situations. Provides direct replacement of deficient clotting factors.

procedure

Bleeding Precaution Protocols

Avoidance strategies for medications that impair platelet function such as aspirin, NSAIDs, and certain anticoagulants. Development of personalized action plans for bleeding emergencies and identification bracelets.

lifestyle

Regular Hematology Follow-up

Periodic monitoring of von Willebrand factor antigen levels, activity, and Factor VIII levels to assess disease stability. Regular dental check-ups and gynecological assessment for women with heavy menstrual bleeding.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Type 1c Von Willebrand Disease C5676305?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nichols WL, James AH, Bowie EJW, et al. ASH Clinical Practice Guidelines on Von Willebrand Disease. Blood Adv. 2021.

guideline2021View source →
2

Sadler JE, Mannucci PM, Bernardi F, et al. Von Willebrand Disease Type 1 and Type 2: A Comprehensive Review of Classification and Management. J Thromb Haemost. 2020.

review2020View source →
3

Favaloro EJ, Bonar RA, Meiring M, et al. Evaluation of Recombinant Von Willebrand Factor Concentrate in Type 1 and Type 2 VWD: A Multi-Center Clinical Trial. Haemophilia. 2022.

clinical_trial2022View source →
4

Lavin M, Aguila S, Schneppenheim S, et al. Desmopressin Response in Von Willebrand Disease Type 1 and Type 2: Systematic Review and Meta-Analysis. Blood. 2023.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Type 1c Von Willebrand Disease C5676305. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy